iBio Inc.


Recent Releases, Events & Media Assets


Latest News

iBio, Inc. Enters into Common Stock Purchase Agreement for Up to $16.0 Million with Lincoln Park Capital

Receives Initial Investment of $1.0 Million NEW YORK, July 24, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE MKT:IBIO) (“iBio”), a leader in developing plant-based biopharmaceuticals, announced today that it has entered into a $16 million common stock purchase agreement with Lincoln Park

Read Press Release

Latest Presentation

Upcoming Event

Dr. Carol Fengali-Bostwick presents at the Scleroderma Foundation – Courtesy of the Scleroderma Foundation, Inc.

Learn More